4.4 Review

The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations

Journal

BIPOLAR DISORDERS
Volume 13, Issue 5-6, Pages 439-453

Publisher

WILEY
DOI: 10.1111/j.1399-5618.2011.00943.x

Keywords

bipolar disorder; depression; mania; nicotine; tobacco

Funding

  1. Department of Veterans Affairs
  2. American Academy of Child and Adolescent Psychiatry
  3. Eli Lilly Co.
  4. CME Outfitters
  5. Consensus Medical Communications, Redo Tour (Adamed)
  6. Web MD
  7. American Psychiatric Association
  8. Nabi Biopharmaceuticals
  9. Sanofi-aventis
  10. Pfizer
  11. AstraZeneca
  12. Johnson Johnson
  13. Shire
  14. Janssen (Johnson Johnson)
  15. Repligen
  16. Bristol-Myers Squibb
  17. Martek
  18. Somerset
  19. Sumitomo
  20. Nutrition 21
  21. GlaxoSmithKline
  22. [DA026517]
  23. [DA022221]
  24. [AA016372]
  25. [MH077138]

Ask authors/readers for more resources

Objectives: Despite recent advances in understanding the causes and treatment of nicotine dependence among individuals with psychiatric disorders, smoking among individuals with bipolar disorder ( BD) has received little attention. The goal of this review is to synthesize the literature on the epidemiology, consequences, and treatment of smoking and nicotine dependence among individuals with BD and to delineate a future research agenda. Methods: We conducted a PubMed search of English-language articles using the search terms bipolar disorder, mania, tobacco, nicotine, and smoking, followed by a manual search of the literature cited in the identified articles. Articles were chosen by the authors on the basis of their relevance to the topic areas covered in this selective review. Results: Adults with BD are two to three times more likely to have started smoking and, on the basis of epidemiological data, may be less likely to initiate and/or maintain smoking abstinence than individuals without psychiatric disorders. Smoking cessation is achievable for individuals with BD, but challenges such as chronic mood dysregulation, high prevalence of alcohol and drug use, more severe nicotine dependence, and limited social support can make quitting more difficult. Effective treatments for tobacco cessation are available, but no controlled trials in smokers with BD have been conducted. Conclusions: Cigarette smoking is a prevalent and devastating addiction among individuals with BD and should be addressed by mental health providers. Additional research on the mechanisms of, and optimal treatment for, smoking and nicotine dependence in this population is desperately needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available